Cite
HARVARD Citation
Leon, S. et al. (2023). Adverse effects during treatment with renin–angiotensin–aldosterone system inhibitors; should we stay or should we stop?. Current opinion in nephrology and hypertension. 32 (3), pp. 290-296. [Online].